MXPA03005980A - Composiciones para administracion nasal de insulina. - Google Patents
Composiciones para administracion nasal de insulina.Info
- Publication number
- MXPA03005980A MXPA03005980A MXPA03005980A MXPA03005980A MXPA03005980A MX PA03005980 A MXPA03005980 A MX PA03005980A MX PA03005980 A MXPA03005980 A MX PA03005980A MX PA03005980 A MXPA03005980 A MX PA03005980A MX PA03005980 A MXPA03005980 A MX PA03005980A
- Authority
- MX
- Mexico
- Prior art keywords
- insulin
- compositions
- nasal administration
- nasal
- administration
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Otolaryngology (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001204784 | 2001-07-05 | ||
| PCT/JP2002/006721 WO2003004048A1 (en) | 2001-07-05 | 2002-07-03 | Compositions for nasal administration of insulin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA03005980A true MXPA03005980A (es) | 2003-09-10 |
Family
ID=19041200
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA03005980A MXPA03005980A (es) | 2001-07-05 | 2002-07-03 | Composiciones para administracion nasal de insulina. |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US6906027B2 (es) |
| EP (1) | EP1413311A4 (es) |
| JP (1) | JP4721212B2 (es) |
| KR (1) | KR20030027108A (es) |
| CN (1) | CN100341567C (es) |
| AU (1) | AU2002346143B2 (es) |
| CA (1) | CA2433583A1 (es) |
| HK (1) | HK1064953A1 (es) |
| MX (1) | MXPA03005980A (es) |
| RU (1) | RU2299743C2 (es) |
| WO (1) | WO2003004048A1 (es) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100341567C (zh) * | 2001-07-05 | 2007-10-10 | 产业化研究株式会社 | 胰岛素的经鼻给药用组合物 |
| US7638138B2 (en) | 2003-02-21 | 2009-12-29 | Translational Research, Ltd. | Compositions for nasal administration of pharmaceuticals |
| AU2003220808B2 (en) | 2003-03-27 | 2008-08-21 | Bioactis Limited | Powder medicine applicator for nasal cavity |
| JP4922762B2 (ja) * | 2004-08-10 | 2012-04-25 | 株式会社新日本科学 | 速効性でかつ高い吸収性を可能とする経鼻投与用組成物 |
| US7115561B2 (en) * | 2004-09-22 | 2006-10-03 | Patterson James A | Medicament composition and method of administration |
| CN101668544B (zh) | 2006-12-26 | 2013-04-24 | 株式会社新日本科学 | 经鼻投用制剂 |
| UA90013C2 (ru) | 2008-03-19 | 2010-03-25 | Давид Анатолійович Нога | Фармацевтическая композиция, содержащая инсулин, и способ его получения |
| EP2429495A4 (en) | 2009-05-15 | 2014-01-22 | Shin Nippon Biomedical Lab Ltd | INTRANASAL PHARMACEUTICAL COMPOSITIONS WITH ENHANCED PHARMACOKINETICS |
| WO2011013003A2 (en) * | 2009-07-31 | 2011-02-03 | Shin Nippon Biomedical Laboratories, Ltd. | Intranasal granisetron and nasal applicator |
| ES2804702T3 (es) | 2013-03-04 | 2021-02-09 | Besins Healthcare Lu Sarl | Composiciones farmacéuticas secas que comprenden nanopartículas de agente activo unidas a partículas de portador |
| WO2015044782A2 (en) * | 2013-09-24 | 2015-04-02 | Shin Nippon Biomedical Laboratories, Ltd. | Intranasal dhe for the treatment of headache |
| US11744967B2 (en) | 2017-09-26 | 2023-09-05 | Shin Nippon Biomedical Laboratories, Ltd. | Intranasal delivery devices |
| WO2019130701A1 (ja) * | 2017-12-26 | 2019-07-04 | 旭化成株式会社 | セルロース粉末 |
| EP3893877A4 (en) | 2018-12-11 | 2022-09-14 | Satsuma Pharmaceuticals, Inc. | COMPOSITIONS, DEVICES AND METHODS FOR TREATMENT OR PREVENTION OF HEADACHE |
| CA3138846A1 (en) * | 2019-05-16 | 2020-11-19 | Shin Nippon Biomedical Laboratories, Ltd. | Powder formulation for intranasal administration, and manufacturing method thereof |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS59163313A (ja) * | 1983-03-09 | 1984-09-14 | Teijin Ltd | 経鼻投与用ペプチドホルモン類組成物 |
| JPS60224616A (ja) * | 1984-04-24 | 1985-11-09 | Teijin Ltd | 経鼻投与用組成物 |
| JPS6242888A (ja) | 1985-08-21 | 1987-02-24 | カシオ計算機株式会社 | 太陽電池を備えたｉｃカ−ド |
| JP2505430B2 (ja) * | 1986-11-04 | 1996-06-12 | 帝人株式会社 | 塩基性アミノ酸を含有する経鼻投与用粉末状組成物 |
| JPH0715963B2 (ja) | 1987-08-31 | 1995-02-22 | 松下電器産業株式会社 | 半導体装置 |
| JP2802488B2 (ja) * | 1995-02-08 | 1998-09-24 | 有限会社ドット | 経鼻吸収用生理活性ペプチド組成物 |
| JP3197221B2 (ja) | 1996-02-27 | 2001-08-13 | 帝人株式会社 | 吸収性が改善された粉末状経鼻投与組成物 |
| JP3634380B2 (ja) | 1996-02-27 | 2005-03-30 | 帝人株式会社 | 粉末状経鼻投与組成物 |
| DE69932144T8 (de) | 1998-08-26 | 2007-10-04 | Teijin Ltd. | Pulverförmige pernasale mittel |
| DE69924504T2 (de) * | 1998-08-26 | 2006-02-16 | Teijin Ltd. | Pulverförmige pernasale mittel |
| CN100341567C (zh) * | 2001-07-05 | 2007-10-10 | 产业化研究株式会社 | 胰岛素的经鼻给药用组合物 |
-
2002
- 2002-07-03 CN CNB028045467A patent/CN100341567C/zh not_active Expired - Fee Related
- 2002-07-03 RU RU2004103187/15A patent/RU2299743C2/ru not_active IP Right Cessation
- 2002-07-03 WO PCT/JP2002/006721 patent/WO2003004048A1/ja active Application Filing
- 2002-07-03 KR KR10-2003-7003165A patent/KR20030027108A/ko not_active Application Discontinuation
- 2002-07-03 JP JP2003510058A patent/JP4721212B2/ja not_active Expired - Lifetime
- 2002-07-03 CA CA002433583A patent/CA2433583A1/en not_active Abandoned
- 2002-07-03 MX MXPA03005980A patent/MXPA03005980A/es active IP Right Grant
- 2002-07-03 AU AU2002346143A patent/AU2002346143B2/en not_active Ceased
- 2002-07-03 EP EP02743793A patent/EP1413311A4/en not_active Withdrawn
- 2002-07-03 US US10/250,862 patent/US6906027B2/en not_active Expired - Fee Related
-
2004
- 2004-10-13 HK HK04107874A patent/HK1064953A1/xx not_active IP Right Cessation
-
2005
- 2005-03-14 US US11/078,292 patent/US20050158250A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JPWO2003004048A1 (ja) | 2005-11-24 |
| WO2003004048A1 (en) | 2003-01-16 |
| RU2004103187A (ru) | 2005-06-10 |
| RU2299743C2 (ru) | 2007-05-27 |
| US20050158250A1 (en) | 2005-07-21 |
| KR20030027108A (ko) | 2003-04-03 |
| CA2433583A1 (en) | 2003-01-16 |
| EP1413311A1 (en) | 2004-04-28 |
| EP1413311A4 (en) | 2005-10-19 |
| US6906027B2 (en) | 2005-06-14 |
| JP4721212B2 (ja) | 2011-07-13 |
| CN100341567C (zh) | 2007-10-10 |
| US20040063615A1 (en) | 2004-04-01 |
| CN1491114A (zh) | 2004-04-21 |
| AU2002346143B2 (en) | 2007-10-04 |
| HK1064953A1 (en) | 2005-02-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL161214A0 (en) | Compositions for delivery of drug combinations | |
| IL158862A0 (en) | An insulin composition for pulmonary administration | |
| EP1438086A4 (en) | NOSE NEEDLE | |
| AU2002352344A8 (en) | Medicament delivery assembly | |
| IL161446A0 (en) | Medicinal compositions for nasal absorption | |
| GB0126151D0 (en) | Administration of medicaments by vaporisation | |
| AU2002248464A1 (en) | Stabilized insulin formulations | |
| AU2002361453A1 (en) | Metered dose inhaler | |
| PL367180A1 (en) | Stabilized oral pharmaceutical composition | |
| AU2002222118A1 (en) | Pharmaceutical compositions for inhalation | |
| AU2002364508A1 (en) | Open-celled substrates for drug delivery | |
| IL157580A0 (en) | Inhalation drug combination | |
| MXPA03005980A (es) | Composiciones para administracion nasal de insulina. | |
| IL151910A0 (en) | Compositions for drug delivery | |
| HK1065257A1 (en) | Medicinal composition | |
| AU2002346143A1 (en) | Compositions for nasal administration of insulin | |
| NO20034556L (no) | Imidazotriazinon-holdige sammensetninger for nasal administrering | |
| GB0304636D0 (en) | Pharmaceutical composition for nasal delivery | |
| HUP0400115A3 (en) | Pharmaceutical composition for the intramuscular administration of fulvestrant | |
| GB0103877D0 (en) | Novel Drug Delivery system | |
| AU2002215114A1 (en) | Pharmaceutical compositions for inhalation | |
| AU2002308649A1 (en) | Compositions and methods for enhancing drug delivery | |
| GB0212790D0 (en) | Medicament for the treatment of diabetes | |
| GB0114746D0 (en) | Medicinal composition | |
| HUP0200253A3 (en) | Pharmaceutical compositions for combination therapy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |